一项随机临床试验,评估数字疗法,以提高帕金森病患者的步行功能
Jay L Alberts1,2, Ryan D Kaya2, Amanda L Penko1
1Department of Biomedical Engineering, Cleveland Clinic, Lerner Research Institute, Cleveland, OH, USA.
Neurorehabilitation and neural repair
|July 19, 2023
概括
使用DART平台进行的数字双任务训练有效地改善了帕金森病患者的步态. 这种增强现实方法显示的结果与传统方法相比不逊色,增加了姿势不稳定性和步行功能障碍的可访问性.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 数字健康数字健康
背景情况:
- 姿势不稳定和步行功能障碍 (PIGD) 是帕金森病 (PD) 的一种主要症状,在双重任务时会恶化.
- 传统的双重任务训练 (DTT) 改善了步态,但资源密集.
- 双任务增强现实处理 (DART) 平台提供了一个数字化解决方案,以提高PIGD的DTT可访问性.
研究的目的:
- 为了比较DART平台与PD患者PIGD传统DTT的疗效.
- 测试DART干预将导致明显的步态改善的假设,与传统的DTT相比.
主要方法:
- 一个单盲随机对照试验涉及47名患有PIGD的PD参与者.
- 参与者在8周内进行了16次治疗,其中一组使用了DART平台 (Microsoft HoloLens2) 和另一组使用传统的DTT.
- 主要结局评估了临床PD症状和单任务和双任务步态生物力学.
主要成果:
- 无论是DART还是传统的DTT群体,都在步行速度,节奏和步骤长度方面表现出显著的改善.
- 在两组干预组中,临床PD症状测量保持稳定.
- 在大多数条件下,DART组的步行速度改善与传统DTT组相比并非劣.
结论:
- DART平台是一个可行的数字治疗方法,用于改善帕金森病患者的PIGD.
- 通过DART提供数字DTT展示了扩大对这种未充分利用的干预措施的获取潜力.
- 这项研究支持DART作为一种有效和可访问的方法来管理PD的步行功能障碍.
相关概念视频
Parkinson's Disease: Treatment
301
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
301
Parkinson's Disease: Overview
601
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
601


